Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1798-1804

  Liu, Zhong Ying ^a   Ganju, Ramesh K ^a   Wang, Jian Feng ^a   Ona, Mel A ^a   Hatch, William C ^a   Zheng, Tong ^b   Avraham, Shalom ^a   Gill, Parkash ^b   Groopman, Jerome E ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

cytokines; Kaposi's sarcoma (KS); RAFTK; related adhesion focal tyrosine kinase

Indexed keywords

CYTOKINE; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ARTICLE; CELL FREE SYSTEM; CELL GROWTH; CELL PROLIFERATION; CYTOSKELETON; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SARCOMA CELL; SIGNAL TRANSDUCTION;

EID: 0030894505     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119344     Document Type: Article

References (48)

1. Dictor, M. 1988. Vascular remodeling in Kaposi's sarcoma and avian hemangiomatosis: relation to the vertebrate lymphatic system. Lymphology. 21: 53-60.
2. Dorfman, R.F. 1988. Kaposi's sarcoma: evidence supporting its origin from the lymphatic system. Lymphalogy. 21:45-52.
3. Chang, Y., E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, and P.S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science (Wash. DC). 266:1865-1869.
4. Zhong, W., H. Wang, H.B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA. 93:6641-6646.
5. Huang, Y.Q., J.J. Li, W.G. Zhang, D. Feiner, and A.E. Friedman-Kien. 1996. Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma. J. Clin. Invest. 97:2803-2806.
6. Humphrey, R.W., T.R. O'Brien, F.M. Newcomb, H. Nishihara, K.M. Wyvill, G.A. Ramos, M.W. Saville, J.J. Goedert, S.E. Straus, and R. Yarchoan. 1996. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood. 88:297-301.
7. Ensoli, B., G. Barillari, S.Z. Salahuddin, R.C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (Lond.). 345:84-86.
8. Barillari, G., L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R.C. Gallo, and B. Ensoli. 1992. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:3727-3734.
9. Buonaguro, L., G. Barillari, H.K. Chang, C.A. Bohan, V. Kao, R. Morgan, R.C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66:7159-7167.
10. Cai, J., P.S. Gill, R. Masood, P. Chandrasoma, B. Jung, R.E. Law, and S.F. Radka. 1994. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am. J. Pathol. 145:74-79.
11. Ensoli, B., G. Barillari, and R.C. Gallo. 1992. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol. Rev. 127:147-155.
12. Ensoli, B., S. Nakamura, S.Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R.C. Gallo. 1989. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrinc growth effects. Science (Wash. DC). 243:223-226.
13. Fiorelli, V., R. Gendelman, F. Samaniego, P.D. Markham, and B. Ensoli. 1995. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 95:1723-1734.
14. Huang, Y.Q., J.J. Li, K.S. Kim, A. Nicolaides, W.G. Zhang, J. Le, B.J. Poiesz, and A.E. Friedman-Kien. 1993. HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro. AIDS (Phila.). 7:317-322.
15. Ganem, D. 1995. AIDS. Viruses, cytokines and Kaposi's sarcoma. Curr. Biol. 5:469-471.
16. Miles, S.A. 1994. Pathogenesis of HIV-related Kaposi's sarcoma. Curr. Opin. Oncol. 6:497-502.
17. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H.K. Chang, J.N. Brady, and R.C. Gallo. 1994. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (Lond.). 371:674-680.
18. Miles, S.A., A.R. Rezai, J.F. Salazar-Gonzalez, M. Vander Meyden, R.H. Stevens, D.M. Logan, R.T. Mitsuyasu, T. Taga, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA. 87:4068-4072.
19. Nair, B.C., A.L. DeVico, S. Nakamura, T.D. Copeland, Y. Chen, A. Patel, T. O'Neil, S. Oroszlan, R.C. Gallo, and M.G. Sarngadharan. 1992. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (Wash. DC). 255:1430-1432.
20. Weindel, K., D. Marme, and H.A. Weich. 1992. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 183:1167-1174.
21. Yang, J., M.K. Hagan, and M.K. Offermann. 1994. Induction of IL-6 gene expression in Kaposi's sarcoma cells. J. Immunol. 152:943-955.
22. Brown, T.J., J.M. Rowe, J.W. Liu, and M. Shoyab. 1991. Regulation of IL-6 expression by oncostatin M. J. Immunol. 147:2175-2180.
23. Buonaguro, L., F.M. Buonaguro, G. Giraldo, and B. Ensoli. 1994. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 68:2677-2682.
24. Maier, J.A., M. Mariotti, A. Albini, P. Comi, M. Prat, P.M. Comogilio, and M.R. Soria. 1996. Over-expression of hepatocyte growth factor in human Kaposi's sarcoma. Int. J. Cancer. 65:168-172.
25. Sciacca, F.L., M. Sturzl, F. Bussolino, M. Sironi, H. Brandstetter, C. Zietz, D. Zhou, C. Matteucci, G. Peri, S. Sozzani, et al. 1994. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J. Immunol. 153:4816-4825.
26. Avraham, S., R. London, Y. Fu, S. Ota, D. Hiregowdara, J. Li, S. Jiang, L.M. Pasztor, R.A. White, J.E. Groopman, and H. Avraham. 1995. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J. Biol. Chem. 270:27742-27751.
27. 2+-induced regulation of ion channel and MAP kinase functions. Nature (Lond.). 376:737-745.
28. Sasaki, H., K. Nagura, M. Ishino, H. Tobioka, K. Kotani, and T. Sasaki. 1995. Cloning and characterization of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J. Biol. Chem. 270: 21206-21219.
29. Li, J., H. Avraham, R.A. Rogers, S. Raja, and S. Avraham. 1996. Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes. Blood. 88:417-428.
30. Kaipainen, A., J. Korhonen, T. Mustonen, V.W. van Hinsbergh, G.-H. Fang, D. Dumont, M. Breitman, and K. Alitalo. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA. 92:3566-3570.
31. Kaipainen, A., J. Korhonen, K. Pajusola, O. Aprelikova, M.G. Persico, B.I. Terman, and K. Alitalo. 1993. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178:2077-2088.
32. Hewett, P.W., and J.C. Murray. 1996. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochem. Biophys. Res. Commun. 221:697-702.
33. Lee, J., A. Gray, J. Yuan, S-M. Luoh, H. Avraham, and W.I. Wood. 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA. 93: 1988-1992.
34. Joukov, V., K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, and K. Alitalo. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO (Eur. Mol. Biol. Organ.) J. 15: 290-298.
35. Tokiwa, G., I. Dikic, S. Lev, and J. Schlessinger. 1996. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science (Wash. DC.). 273:792-794.
36. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R.J. Davis. 1994. JNK-1: a protein-kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1025-1037.
37. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
38. Kallunki, T., B. Su, I. Tsigelny, H.K. Sluss, B. Derijard, G. Moore, R. Davis, and M. Karin. 1994. JNK2 contains a specificity determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8:2996-3007.
39. Faris, M., B. Ensoli, N. Stahl, G. Yancopoulis, A. Nguyen, S. Wang, and A.E. Nel. 1996. Differential activation of the extracellular signal-regulated kinase, Jun Kinase and Janus Kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. AIDS (Phila.). 10:369-378.
40. Masood, R., S.R. Husain, A. Rahman, and P. Gill. 1993. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res. Hum. Retroviruses. 9:741-746.
41. Masood, R., Y. Lunardi-Iskandar, L.F. Jean, J.R. Murphy, C. Waters, R.C. Gallo, and P. Gill. 1994. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res. Hum. Retroviruses. 10:969-975.
42. Guo, W., T. Antakly, M. Cadotte, Z. Kachra, L. Kunkel, R. Masood, and P.S. Gill. 1996. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma. Am. J. Pathol. 148:1999-2007.
43. Brown, L.F., K. Tognazzi, H.F. Dvorak, and T.J. Harrist. 1996. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am. J. Pathol. 148:1065-1074.
44. MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth. J. Clin. Invest. 92:848-857.
45. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun protooncogene is positively autoregulated by its product. Jun/AP-1. Cell. 55:875-885.
46. Salgia, R., S. Avraham, E. Pisick, J.-L. Li, S. Raja, E.A. Greenfield, M. Sattler, H. Avraham, and J.D. Griffin. 1996. The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J. Biol. Chem. 271: 31222-31226.
47. Clark, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways. Science (Wash. DC). 268:233-239.
48. Bellis, S.L., J.T. Miller, and C.E. Turner. 1995. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem. 270:17437-17441.